{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T08:13:14Z","timestamp":1777882394399,"version":"3.51.4"},"reference-count":49,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T00:00:00Z","timestamp":1772236800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T00:00:00Z","timestamp":1772236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Therapeutic Advances in Rare Disease"],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Primary Biliary Cholangitis (PBC) is a chronic, progressive liver disease. This paper outlines how a PBC patient registry was developed to address the gaps in evidence, care and policy affecting PBC patients in Ireland.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>The PBC patient registry is designed to collect patient-reported data regarding medical history, pruritus, fatigue and quality of life of PBC patients living in Ireland. This data can be used to identify care and treatment gaps and ensure that the PBC patient voice is included in new treatment decisions and healthcare policy. This real-world data will support further scientific and clinical research, drive patient-led advocacy efforts and facilitate collaboration with the liver disease communities globally.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design:<\/jats:title>\n                    <jats:p>A patient-led, observational, registry-based study of PBC patients in Ireland.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis:<\/jats:title>\n                    <jats:p>Participants must have a PBC diagnosis and be 18\u2009years of age or older. PROMs (patient-reported outcome measures) were administered through a secure web-based system. After providing electronic informed consent, participants completed online data collection forms. These included demographic information, medical history, standard of care and validated PROMs for fatigue, pruritus and quality of life. This was followed by an anonymous survey to collect usability and comprehensiveness metadata.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics:<\/jats:title>\n                    <jats:p>The protocol was approved by TIER IRB Services, protocol ID: 5250715 (July 18th, 2025), which determined the study to be exempt as an observational, minimal-risk, non-interventional research activity involving anonymised patient-reported data.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion:<\/jats:title>\n                    <jats:p>At the time of publication, 52 participants were registered in the patient registry, of which 40 completed all data collection forms. The results of the post-completion survey suggest high satisfaction across the domains of usability, comprehension, relevance, privacy\/confidentiality and overall experience. The PBC patient registry shows that web-based PROMs can be used to collect real-world evidence from patients. Participants reported that the system was easy to use and comprehensive, confirming the usability and effectiveness of this approach. It also provides a starting point to identify healthcare and treatment gaps and facilitates the inclusion of PBC patients\u2019 voices in national and international health policy decisions that affect them.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial Registration:<\/jats:title>\n                    <jats:p>Not applicable.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/26330040261427491","type":"journal-article","created":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T17:28:33Z","timestamp":1772299713000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["The PBC Ireland patient registry: study protocol for a national platform on primary biliary cholangitis"],"prefix":"10.1177","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1065-9266","authenticated-orcid":false,"given":"Gerry","family":"Nesbitt","sequence":"first","affiliation":[{"name":"PBC Ireland, Garristown, Co. Dublin, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-3892-719X","authenticated-orcid":false,"given":"Alexandra","family":"Curley","sequence":"additional","affiliation":[{"name":"PBC Ireland, Dublin, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2026,2,28]]},"reference":[{"key":"e_1_3_3_2_2","unstructured":"PBC Ireland. PBC Ireland https:\/\/pbcireland.org (2025 accessed 24 August 2025)."},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.7812\/TPP\/23.103"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.20517\/rdodj.2023.39"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-67144-4_30"},{"key":"e_1_3_3_6_2","unstructured":"Rare diseases and European Reference Networks. European Reference Networks https:\/\/health.ec.europa.eu\/rare-diseases-and-european-reference-networks\/rare-diseases_en (2025 accessed 8 August 2025)."},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1007\/s44162-025-00099-6"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.rare.2024.100018"},{"key":"e_1_3_3_9_2","unstructured":"European Commission. European Reference Networks https:\/\/health.ec.europa.eu\/rare-diseases-and-european-reference-networks\/european-reference-networks_en (2025 accessed 10 August 2025)."},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1097\/HC9.0000000000000179"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0034-1383726"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10061288"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20907"},{"key":"e_1_3_3_14_2","article-title":"Global epidemiology of primary biliary cholangitis: an updated systematic review and meta-analysis","author":"Jie-Rae Tan J","unstructured":"Jie-Rae Tan J, Lam Chung AH, Loo JH, et al. Global epidemiology of primary biliary cholangitis: an updated systematic review and meta-analysis. Clin Gastroenterol Hepatol. Epub ahead of print 2025;","journal-title":"Clin Gastroenterol Hepatol"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.3390\/cells13181580"},{"key":"e_1_3_3_16_2","unstructured":"European Medicines Agency. EMA recommends revoking conditional marketing authorisation for Ocaliva https:\/\/www.ema.europa.eu\/en\/news\/ema-recommends-revoking-conditional-marketing-authorisation-ocaliva (2025 accessed 12 August 2025)."},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-025-09177-7"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-020-01664-0"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.12775\/QS.2024.23.55038"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.3631"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2306185"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2312100"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-025-01538-4"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.03.022"},{"key":"e_1_3_3_25_2","first-page":"15","article-title":"Primary biliary cholangitis: 2018 practice guidance from the American Association for the Study of liver diseases","author":"Lindor KD","year":"2020","unstructured":"Lindor KD, Bowlus CL, Boyer J, et al. Primary biliary cholangitis: 2018 practice guidance from the American Association for the Study of liver diseases. Clin Liver Dis 2020; 15.","journal-title":"Clin Liver Dis"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2017-315259"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-021-10276-6"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1136\/flgastro-2020-101713"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2025.01.037"},{"key":"e_1_3_3_30_2","doi-asserted-by":"crossref","DOI":"10.23970\/AHRQEPCREGISTRIES4","volume-title":"Registries for evaluating patient outcomes: a user\u2019s guide fourth edition registries for evaluating patient outcomes: a user\u2019s guide","author":"Gliklich RE","year":"2020","unstructured":"Gliklich RE, Leavy MB, Dreyer NA (sr eds). Registries for evaluating patient outcomes: a user\u2019s guide fourth edition registries for evaluating patient outcomes: a user\u2019s guide. AHRQ Publication, 2020; 19(20)-EH."},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.1414"},{"key":"e_1_3_3_32_2","unstructured":"Worldometers. Population of Ireland [Internet]. Available from: https:\/\/www.worldometers.info\/world-population\/ireland-population\/ (2025 accessed 12 August 2025)."},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-017-0597-1"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.4103\/jpgm.JPGM_230_21"},{"issue":"1","key":"e_1_3_3_35_2","article-title":"Patient-led research collaborative: embedding patients in the long COVID narrative","volume":"6","author":"McCorkell L","year":"2021","unstructured":"McCorkell L, Assaf GS, Davis HE, et al. Patient-led research collaborative: embedding patients in the long COVID narrative. Pain Rep 2021; 6(1): e913.","journal-title":"Pain Rep"},{"issue":"2","key":"e_1_3_3_36_2","first-page":"276","article-title":"Patient-led research and displacements of biomedical knowledge production, distribution, and consumption. Health: an Interdisciplinary","volume":"29","author":"Strand DL","year":"2025","unstructured":"Strand DL, Holen M. Patient-led research and displacements of biomedical knowledge production, distribution, and consumption. Health: an Interdisciplinary J Social Study Health Illness Med 2025; 29(2): 276\u2013294.","journal-title":"J Social Study Health Illness Med"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1186\/s40900-018-0104-4"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-014-2895-9"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40271-020-00493-w"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.14309\/ctg.0000000000000709"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/18.Supplement_1.S79"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2008.151340"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.1186\/s41687-023-00645-0"},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2009.09586.x"},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/3896423"},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.1111\/apt.15554"},{"key":"e_1_3_3_47_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2005.065862"},{"key":"e_1_3_3_48_2","unstructured":"CLIRINX. Clinical Research IT [Internet] https:\/\/clirinx.com (2025 accessed 12 August 2025)."},{"key":"e_1_3_3_49_2","unstructured":"Amazon AWS. Amazon AWS [Internet] https:\/\/aws.amazon.com\/health\/healthcare-compliance\/ (2025 accessed 23 August 2025)."},{"key":"e_1_3_3_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.imu.2022.100973"}],"container-title":["Therapeutic Advances in Rare Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/26330040261427491","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/26330040261427491","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/26330040261427491","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T01:10:56Z","timestamp":1777597856000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/26330040261427491"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,28]]},"references-count":49,"alternative-id":["10.1177\/26330040261427491"],"URL":"https:\/\/doi.org\/10.1177\/26330040261427491","relation":{},"ISSN":["2633-0040","2633-0040"],"issn-type":[{"value":"2633-0040","type":"print"},{"value":"2633-0040","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,28]]},"article-number":"26330040261427491"}}